These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 19065526)

  • 1. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
    Jia D; Jiang H; Tang B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
    Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
    J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machado-Joseph disease/spinocerebellar ataxia type 3.
    Paulson H
    Handb Clin Neurol; 2012; 103():437-49. PubMed ID: 21827905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report.
    Bettencourt C; Santos C; Coutinho P; Rizzu P; Vasconcelos J; Kay T; Cymbron T; Raposo M; Heutink P; Lima M
    BMC Neurol; 2011 Oct; 11():131. PubMed ID: 22023810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
    Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP
    Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
    Matos CA; de Macedo-Ribeiro S; Carvalho AL
    Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features and gene mutation analysis in Machado-Joseph disease of spinocerebellar ataxia type 3 in littoral of Zhejiang].
    Jin YY; Zeng AP; Cai HB; Wu F; Feng Z; Hong Q; Zhang L; Jiang ZK
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Apr; 23(2):132-4. PubMed ID: 20104758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.
    Colomer Gould VF; Goti D; Pearce D; Gonzalez GA; Gao H; Bermudez de Leon M; Jenkins NA; Copeland NG; Ross CA; Brown DR
    Neurobiol Dis; 2007 Sep; 27(3):362-9. PubMed ID: 17632007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
    Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.
    Geschwind DH; Perlman S; Figueroa CP; Treiman LJ; Pulst SM
    Am J Hum Genet; 1997 Apr; 60(4):842-50. PubMed ID: 9106530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease.
    Cancel G; Gourfinkel-An I; Stevanin G; Didierjean O; Abbas N; Hirsch E; Agid Y; Brice A
    Hum Mutat; 1998; 11(1):23-7. PubMed ID: 9450899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machado-Joseph disease and other rare spinocerebellar ataxias.
    Matilla-Dueñas A
    Adv Exp Med Biol; 2012; 724():172-88. PubMed ID: 22411243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala.
    Martins S; Soong BW; Wong VC; Giunti P; Stevanin G; Ranum LP; Sasaki H; Riess O; Tsuji S; Coutinho P; Amorim A; Sequeiros J; Nicholson GA
    Arch Neurol; 2012 Jun; 69(6):746-51. PubMed ID: 22351852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of Machado-Joseph disease/Spinocerebellar Ataxia Type 3 in Taiwan: early detection of expanded ataxin-3.
    Tsai HF; Liu CS; Chen GD; Lin ML; Li C; Chen YY; Wang BT; Hsieh M
    J Clin Lab Anal; 2003; 17(5):195-200. PubMed ID: 12938149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients.
    Schöls L; Vieira-Saecker AM; Schöls S; Przuntek H; Epplen JT; Riess O
    Hum Mol Genet; 1995 Jun; 4(6):1001-5. PubMed ID: 7655453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the mammalian DNA end-processing enzyme polynucleotide kinase 3'-phosphatase in spinocerebellar ataxia type 3 pathogenesis.
    Chatterjee A; Saha S; Chakraborty A; Silva-Fernandes A; Mandal SM; Neves-Carvalho A; Liu Y; Pandita RK; Hegde ML; Hegde PM; Boldogh I; Ashizawa T; Koeppen AH; Pandita TK; Maciel P; Sarkar PS; Hazra TK
    PLoS Genet; 2015 Jan; 11(1):e1004749. PubMed ID: 25633985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caring for Machado-Joseph disease: current understanding and how to help patients.
    D'Abreu A; França MC; Paulson HL; Lopes-Cendes I
    Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the rat spinocerebellar ataxia type 3 gene.
    Schmitt I; Brattig T; Gossen M; Riess O
    Neurogenetics; 1997 Sep; 1(2):103-12. PubMed ID: 10732811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.